Chao Qi began their work experience in 2011 at Boston University, where they completed their PHD from September 2011 to September 2016. They then joined Incyte in October 2016 as a Research Investigator and was promoted to Senior Research Investigator in August 2018. In December 2020, Chao Qi became a Principal Investigator at Incyte before transitioning to their current role as an Associate Director at Synnovation Therapeutics in September 2021.
Chao Qi completed a Bachelor's Degree in Medicinal and Pharmaceutical Chemistry from Peking University Health Science Center, from 2007 to 2011. Following this, Chao Qi pursued a Doctor of Philosophy (Ph.D.) in Organic Chemistry at Boston University, from 2011 to 2016.
Sign up to view 0 direct reports
Get started
This person is not in any teams